Q: I’m taking a GLP-1 to help me control my blood sugar and lose weight. But the cost and side effects of having to do resistance exercise make it difficult ...

As a physician who prescribes GLP-1 medications like Ozempic, Wegovy, semaglutide, and tirzepatide, I explain why increasing ...

A recent small study has found that people may be able to maintain their weight loss with fewer GLP-1 injections, but this ...

A new study suggests that widely used GLP-1 weight-loss drugs may do more than improve metabolic health: they could also protect the heart after a heart attack. Doctors can often reopen the blocked ...

They can make or break your experience, and your doctor might not have mentioned them.

The cessation of GLP-1RAs is linked to a 60% weight regain within a year, emphasizing the importance of tailored strategies for effective long-term weight loss.

Three scientists whose work at different stages led to the development of semaglutide – a breakthrough treatment for obesity, diabetes and other cardiometabolic diseases – have been recognised with a ...

Janus Henderson Forty Fund returned 0.27% and the Russell 1000® Growth Index returned 1.12%. U.S. shares rose on positive corporate earnings news. Economic growth has been relatively stable despite a ...

HealthDay News — Adults with overweight or obesity regain much of their lost weight after cessation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), according to a review published online ...

Weight-loss drugs may prevent deadly heart complications by opening blocked blood vessels after heart attacks, groundbreaking ...

Driven by high prices, lack of insurance, and a desire to lose weight, the proliferation of fake and falsified obesity drugs is prompting public health concern. Sophie Cousins reports.

Q4 2025 Earnings Call March 5, 2026 4:30 PM ESTCompany ParticipantsAllan Kells - Vice President of Investor RelationsSean Duffy ...